Cencora (COR) vs EnerSyn Global (ESYN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Cencora (COR) has outperformed EnerSyn Global (ESYN) over the past year, gaining 2.8% versus a loss of 27.2%. Cencora is the larger company by market cap ($60.54 billion vs $61.2 million), about 988.6 times the size. Cencora pays a dividend yielding 0.74%, while EnerSyn Global does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | COR | ESYN |
|---|---|---|
| Share price | $317.25 | $2.06 |
| Market cap | $60.54B | $61.24M |
| 1-day change | +0.28% | -1.90% |
| YTD return | -6.07% | +38.26% |
| 1-year return | +2.77% | -27.21% |
| 5-year return | +164.68% | — |
| P/E ratio (TTM) | 23.55 | — |
| Forward P/E | 16.02 | — |
| EPS (TTM) | $13.47 | $-0.39 |
| Dividend yield | 0.74% | 0.00% |
| Annual dividend | $2.35 | $0.00 |
| Revenue (latest FY) | $321.33B | — |
| Revenue growth (YoY) | +9.31% | — |
| Net income (latest FY) | $1.55B | — |
| Gross margin | 3.57% | — |
| Operating margin | 0.82% | — |
| Net margin | 0.48% | — |
| 52-week high | $377.54 | $2.81 |
| 52-week low | $244.82 | $0.88 |
| Distance from 52-week high | -15.97% | -26.69% |
| Analyst consensus | buy | — |
| Avg. price target upside | +16.39% | — |
| Average volume | 1.34M | 164.43K |
| Shares outstanding | 190.83M | 29.73M |
| Employees | 47,000 | — |
| Sector | Health Care | Health Care |
| Industry | Other Pharmaceuticals | Other Pharmaceuticals |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Cencora is about 988.6 times larger than EnerSyn Global by market value ($60.54B vs $61.24M).
- COR has outperformed ESYN by 30.0 percentage points over the past year.
About Cencora
COR stock →Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally.
Health Care · Other Pharmaceuticals · 47,000 employees
COR vs ESYN FAQ
Which is bigger, Cencora or EnerSyn Global?
Cencora (COR) is larger, with a market capitalization of $60.54B compared with $61.24M for EnerSyn Global (ESYN).
Which stock has performed better over the past year, COR or ESYN?
COR returned +2.77% over the past 12 months, compared with -27.21% for ESYN (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Cencora or EnerSyn Global?
Cencora pays a dividend yielding 0.74%, while EnerSyn Global does not currently pay a regular dividend.
Are Cencora and EnerSyn Global in the same industry?
Yes. Both are classified in the Other Pharmaceuticals industry within the Health Care sector.